Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient

Critical Care Medicine

Volumn 30, Issue 10, 2002, Pages 2249-2254

  Taylor, Robert W ^a   Manganaro, Lisa ^a   O'Brien, Jacklyn ^a   Trottier, Steven J ^a   Parkar, Nadeem ^a   Veremakis, Christopher ^a  

^a ST JOHN S MERCY MEDICAL CENTER   (United States)

Author keywords

Anemia; Blood transfusion; Immune modulation; Immune response; Infection; Intensive care unit; Nosocomial infection; Packed red blood cells; Red blood cells; Transfusion

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CRITICAL ILLNESS; ERYTHROCYTE CONCENTRATE; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL;

EID: 0036796878     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200210000-00012     Document Type: Article

References (68)

1. Corwin HL, Parsonnet KC, Gettinger A: RBC transfusion in the ICU: Is there a reason? Chest 1995; 108:767-771
2. Smoller BR, Kruskall MS: Phlebotomy for diagnostic laboratory tests in adults: Pattern of use and effect on transfusion requirements. N Engl J Med 1986; 314:1233-1235
3. Groeger JS, Guntapalli KK, Strosberg M, et al: Descriptive analysis of critical care units in the United States: Patient characteristics and intensive care utilization. Crit Care Med 1993; 21:279-291
4. Hebert PC, Wells G, Marshall J, et al: Transfusion requirements in critical care: A pilot study. JAMA 1995; 274:944
5. Littenberg B, Corwin HC, Gettinger: A et al: A practice guideline and decision aide for blood transfusion. Immunohematology 1995; 11:88-94
6. Consensus conference: Perioperative red blood cell transfusion. JAMA 1988; 260: 2700-2703
7. American College of Physicians: Practice strategies for elective red blood cell transfusion. Ann Intern Med 1992; 116:403-406
8. Expert Working Group: Guidelines for red blood cell and plasma transfusion for adults and children. Can Med Assoc J 1997; 156(Suppl II):S1-S24
9. Tarpey J, Lawler PG: Iatrogenic anemia? A survey of venesection in patients in the intensive therapy unit. Anaesthesia 1990; 45: 396-398
10. Maukkassa FF, Rutledge R, Fakhry SM, et al: ABGs and arterial lines: The relationship to unnecessarily drawn arterial blood gas samples. J Trauma 1990; 30:1087-1095
11. Low LL, Harrington GR, Stoltzfus DP: The effect of arterial lines on blood-drawing practices and costs in intensive care units. Chest 1995; 108:216-219
12. Hebert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340:409-417
13. Walker RH: Transfusion risks. Am J Clin Pathol 1987; 88:374-378
14. Aach RD, Szmuness W, Mosley JW, et al: Serum alanine amino-transferase of donors in relation to the risk of non-A, non-B, hepatitis in recipients: The transfusion-transmitted viruses study. N Engl J Med 1681; 304:989-994
15. Alter HJ, Hoofnagle JH: Non-A, non-B: Observations of the first decade. In: Viral Hepatitis and Liver Disease. Vyas GN, Dienstag JL, Hoofnagle JH (Eds). Orlando, FL, Grune and Stratton, 1984, pp 345-354
16. Alter HJ, Purcell RH, Feinstone SM, et al: Non-A/non-B hepatitis: A review and interim report of an ongoing prospective study. In: Viral Hepatitis. Vyas GN, Cohen SN, Schmid R (Eds). Philadelphia, Franklin Institute Press, 1978, pp 359-369
17. Alter HJ, Purcell RH, Holland PV, et al: Donor transaminase and recipient hepatitis. JAMA 1981; 246:630-634
18. Hollinger FB, Mosley JW, Szmuness W, et al: Non-A, non-B hepatitis following blood transfusion: Risk factors associated with donor characteristics. In: Viral Hepatitis: 1981 International Symposium. Szmuness W, Alter HJ, Maynard JE (Eds). Philadelphia, Franklin Institute Press, 1981, pp 361-366
19. Hoofnagle JH, Alter HJ: Chronic viral hepatitis. In: Viral Hepatitis and Liver Disease. Vyas GN, Dienstag JL, Hoofnagle JH. Orlando, FL, Grune and Stratton, 1984, pp 108-109
20. Koziol DE, Holland PV, Alling DW, et al: Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986; 104:488-495
21. Seef LB, Wright EC, Zimmerman HJ, et al: Post-transfusion hepatitis, 1973-1975: A Veterans Administration cooperative study. In: Viral Hepatitis. Vyas GN, Cohen SN, Schmid R (Eds). Philadelphia, Franklin Institute Press, 1978, pp 371-381
22. Walker RH: Is a crossmatch using the indirect antiglobulin test necessary for patients with a negative antibody screen? In: Safety in transfusion practices. Polesky HF, Walker Skokie RH (Eds). Northfield, College of American Pathologists, 1982, p 103
23. Walker RH: Transfusion reactions. In: Current Methods in Blood Banking and Immuno-Hematology. Polesky HF, Walker RH (Eds). Chicago, American Society of Clinical Pathologists, 1986, p 1
24. Popovosky MA, Moore SB: Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25:573-577
25. Taswell HF, Pineda AA, Moore SB: Hemolytic transfusion reactions: Frequency and clinical and laboratory aspects. In: A Seminar on Immunomediated Cell Destruction. Bell CA (Eds). Washington, DC, American Association of Blood Banks, 1681, p 84
26. Pineda AA, Taswell HF: Transfusion reactions associated with anti-IgA antibodies: Report of four cases and review of the literature. Transfusion 1975; 15:10-15
27. Myhre BA: Bacterial contamination is still a hazard of blood transfusion. Arch Pathol Lab Med 1985; 109:982-983
28. Tabor E: Infectious Complications of Blood Transfusion. New York, Academic Press, 1982
29. Brubaker DB: Human posttransfusion graftversus-host disease. Vox Sang 1983; 45: 401-420
30. Annual Reports of the American Association of Blood Banks, 1978-1985, Bethesda, American Association of Blood Banks
31. Centers for Disease Control, June 1987, personal communication
32. Hardy AM, Allen JR, Morgan WM, Curran JW: The incidence rate of acquired immunodeficiency syndrome in selected populations. JAMA 1685; 253:215-220
33. Holmberg S, Peterman T: Transfusion-associated AIDS statistics. Vol. 3. National Heart, Lung and Blood Institute's AIDS Working Group, October 24, 1986, Blood Bank Week. Arlington JC (Ed), American Association of Blood Banks, 1986, pp 1-4
34. Kolins J: The continued risk of transfusion-transmitted AIDS. Pathologist 1986; 40:9
35. Zuck T: Interview with Washington Post, cited in American Medical News, November 14, 1986, p 11
36. Erslev AJ: Production of erythrocytes. In: Hematology. Third Edition. Williams WJ, Beutler E, Erslev AJ (Eds). New York, McGrawHill, 1683, p 360
37. d'Apice AJF, Tait BD: An elective transfusion policy: Sensitization rates, patient transplant-ability, and transplant outcome. Transplantation 1982; 33:191-195
38. Salvatierro O, Vincenti F, Amend W, et al: Deliberate donor specific blood transfusion prior to living related renal transplantation. Ann Surg 1980; 192:543-552
39. Prince AM, Szmuness W, Millian SJ, et al: A serologic study of cytomegalovirus infections associated with blood transfusion. N Engl JMed 1971; 284:1125-1131
40. Tolkoff-Rubin NE, Rubin RH, Keller EE, et al: Cytomegalovirus infection in dialysis patients and personnel. Ann Intern Med 1978; 89:625-628
41. Yeager AS, Grumet FC, Hafleigh EB, et al: Prevention of transfusion-acquired cytomegalo-virus infections in newborn infants. J Pediatr 1981; 98:281-287
42. Giblett ER: A critique of the theoretical hazard of inter vs. intra-racial transfusion. Transfusion 1961; 1:233-238
43. Lostumbo MM, Holland PV, Schmidt PJ: Isoimmunization after multiple transfusions. N Engl J Med 1966; 275:141-144
44. Henle W, Henle G, Scriba M, et al: Antibody responses to the Epstein-Barr virus and cytomegalovirus after open-heart and other surgery. N Engl J Med 1970; 282:1068-1074
45. Unanue ER, Kiely J-M: Synthesis and secretion of a mitogenic protein by macrophages: Description of a superinduction phenomenon. J Immunol 1977; 119:925-931
46. Dahlen SE, Bjork J, Hedqvist P, et al: Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: In vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci U S A 1981; 78:3887-3891
47. Vyas GN, Holmdahl L, Perkins HA, et al: Serological specificity of human anti-IgA and its significance in transfusion. Blood 1969; 34:573-581
48. Dunstan RA, Rosse WF: Posttransfusion purpura. Transfusion 1985; 25;219-222
49. Goodnough LT, Brecher ME, Kanter MH, et al: Transfusion medicine: Blood transfusion. N Engl J Med 1999; 340:438-47
50. Blumberg N, Heal JM: Effects of transfusion on immune function. Arch Pathol Lab Med 1994; 118:371-379
51. Landers DF, Hill GE, Wong KC, et al: Blood transfusion-induced immunomodulation. Anesth Analg 1996; 82:187-204
52. Mickler TA, Longnecker DE: The immunosuppressive aspects of blood transfusion. J Intensive Care Med 1992; 7:176-188
53. Triulzi DJ, Heal JM, Blumberg N: Transfusion-induced immunomodulation and its clinical consequences. In: Transfusion Therapy in the 1990s. Nance SJ (Ed). Arlington, VA: American Association of Blood Banks, 1990, pp 1-32
54. Bordin JO, Heddle NM, Blajchman MA: Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994; 84:1703-1721
55. Nichols RL, Smith JW, Klein DB, et al: Risk of infection after penetrating abdominal trauma. N Engl J Med 1984; 311:1065-1070
56. Edna TH, Bjerkeset T: Association between blood transfusion and infection in injured patients. J Trauma 1992; 33:659-661
57. Vamvakas EC, Carven JH: Allogeneic blood transfusion, hospital charges, and length of hospitalization: A study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 1998; 122: 145-151
58. Dawes LG, Aprahamian C, Condon RE, et al: The risk of infection after colon injury. Surgery 1986; 100:796-803
59. Tartter PI, Quintero S, Barron DM, et al: Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg 1986; 152: 479-482
60. Braga M, Vignali A, Radaelli G, et al: Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer. Eur J Surg 1992; 158:531-536
61. Ottino G, De Paulis R, Pansini S, et al: Major sternal wound infection after open heart surgery: A multivariate analysis of risk factors in 2,579 consecutive procedures. Ann Thorac Surg 1987; 44:173-179
62. Dellinger PE, Miller SD, Wertz MJ, et al: Risk of infection after open fracture of the arm or leg. Arch Surg 1988; 123:1320-1327
63. Graves TA, Captain MC, Cioffi WG, et al: Relationship of transfusion and infection in a burn population. J Trauma 1989; 29: 948-954
64. Lemeshow S, Teres D, Klar J, et al: Mortality probability models (MPM II) based on an international cohort of intensive care unit patients. JAMA 1993; 270:2470-2486
65. Moore FA, Moore EE, Sauaia A: Blood transfusion: An independent risk factor for postinjury multiple organ failure. Arch Surg 1997; 132:620-625
66. Corwin HL, Rodriquez RM, Pearl RG, et al: Efficacy of recombinant erythropoietin in critically ill patients: A randomized, double blind, placebo controlled trial. Crit Care Med 1999; 11:2346-2350
67. Blumberg N, Heal JM: Blood transfusion immunomodulation: The silent epidemic. Arch Pathol Lab Med 1998; 122:117-119
68. Marik PE, Sibbald WJ: Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269:3024-3029